Genetic Testing Market

Genetic Testing Market by Product (Consumables, Equipment, Software & Services), Technology (NGS, PCR, FISH), Testing Type (Predictive & Presymptomatic, Carrier, Prenatal & Newborn, Preimplantation), Methods (Molecular, Genetic, Biochemical), End User (Hospitals, Clinical Labs) - Global Forecast to 2027

Report Code: UC 1129 Dec, 2022, by marketsandmarkets.com

“High volume of genetic screening tests to screen cancer, fetal abnormalities, and other genetic anomalies. The increasing trend of next generation screening for various research studies, personalized medicines and direct-to-consumer genetic testing are pushing the growth of the Genetic Testing Market.”

The global Genetic Testing Market is expected to reach USD xx billion by 2027 from USD xx billion in 2022, at a CAGR of xx%. The growth in this market is driven by the increasing prevalence of the genetic disorders, increasing cases of cancer, and genetic anomalies in newborn. The increasing awareness of genetic testing for screening cancer, pre-natal genetic screening of the increasing use of next generation sequencing (NGS) for the studies of various genetic diseases are pushing the growth of the market.

Genetic Testing Market

To know about the assumptions considered for the study, Request for Free Sample Report

“The consumables segment held the largest market share in 2021.”

Based on product, the Genetic Testing Market is segmented into consumables, equipment, software and services. The consumable segment held the largest share in 2021, which is driven by the high volume of consumables consumed in the genetic tests.

“The next generation sequencing segment is accounted for the largest share in 2021.”

Based on the technology, the Genetic Testing Market is segmented into Next-Generation Sequencing, Polymerase Chain Reaction, Fluorescence in Situ Hybridization, Chemiluminescence Immunoassay, and Other Technologies. The Next generation Sequencing segment is held the largest share owing to its increasing usage for the detection, studies and management of genetic disorders.

“Asia Pacific is estimated to register the highest CAGR during the study period. North America is expected to dominate the market share”

In this report, the Genetic Testing Market is segmented into four major regional segments, namely, North America, Europe, Asia Pacific, Middle East & Africa and Latin America. North America to dominate the market in 2021, owing to its advanced genetic testing technologies, massive volume of genetic testing, and increasing prevalance of genetic disorders. The increasing awarenss and government programs and support for the genetic testing are also promoting the market growth.

Asia Pacific Market is expected to grow at the fastest CAGR during the forecast period of 2022 to 2027, this is attributed to the vast geriatric popualtion, expaniding population base, huge volume of genetic testing due to the massive prevalance of genetic diseases, increasing use of genetic tests for cancer screening, pre-natal screening and other genetic anomalies.

To know about the assumptions considered for the study, download the pdf brochure

Breakdown of primary supply-side interviews, by company type, designation, and region:

  • By Company Type - Tier 1: 48%, Tier 2: 40%, and Tier 3: 12%
  • By Designation - C-level: 44%, D-level: 30%, and Others: 26%
  • By Region: North America (34%), Europe (26%), AsiaPacific (23%), and Rest of the World (17%)

List of Companies Profiled in the Report

  • F. Hoffmann-La Roche Ltd.
  • Abbott Laboratories
  • Thermo Fisher Scientific, Inc.
  • Agilent Technologies, Inc.
  • Bio-Rad Laboratories, Inc.
  • Illumina, Inc.
  • QIAGEN
  • Siemens Healthinier
  • Danaher Corporation
  • Hologic, Inc.
  • PerkinElmer Inc.
  • Myriad Genetics Inc.
  • Sysmex Corporation

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

TABLE OF CONTENTS

1 INTRODUCTION
    1.1 OBJECTIVES OF THE STUDY
    1.2 MARKET DEFINITION
    1.3 MARKET SCOPE
           1.3.1 MARKETS COVERED
           1.3.2 YEARS CONSIDERED FOR THE STUDY
    1.4 CURRENCY
    1.5 LIMITATIONS
    1.6 STAKEHOLDERS

2 RESEARCH METHODOLOGY
    2.1 RESEARCH DATA
           2.1.1 SECONDARY DATA
                    2.1.1.1 Key data from secondary sources
           2.1.2 PRIMARY DATA
                    2.1.2.1 Key data from primary sources
    2.2 MARKET SIZE ESTIMATION
           2.2.1 BOTTOM-UP APPROACH
           2.2.2 TOP-DOWN APPROACH
    2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
    2.4 ASSUMPTIONS FOR THE STUDY

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

5 MARKET OVERVIEW
    5.1 INTRODUCTION
    5.2 MARKET DYNAMICS
           5.2.1 DRIVERS
           5.2.2 RESTRAINTS
           5.2.3 OPPORTUNITIES
           5.2.4 CHALLENGES
    5.4 ECOSYSTEMS ANALYSIS
    5.5 SUPPLY CHAIN ANALYSIS
    5.6 PRICING ANALYSIS

6 GENETIC TESTING MARKET, BY PRODUCT 
    6.1 INTRODUCTION
    6.2 CONSUMABLES
    6.3 EQUIPMENT
    6.4 SOFTWARE AND SERVICES
    6.5 COVID-19 IMPACT ANALYSIS

7 GENETIC TESTING MARKET, BY TECHNOLOGY 
    7.1 INTRODUCTION
    7.2 NEXT-GENERATION SEQUENCING
    7.3 POLYMERASE CHAIN REACTION
    7.4 FLUORESCENCE IN SITU HYBRIDIZATION
    7.5 CHEMILUMINESCENCE IMMUNOASSAY
    7.6 OTHER TECHNOLOGIES
    7.7 COVID-19 IMPACT ANALYSIS

8 GENETIC TESTING MARKET, BY TESTING TYPE 
    8.1 INTRODUCTION
    8.2 PREDICTIVE TESTING AND PRESYMPTOMATIC TESTING
    8.3 CARRIER TESTING
    8.4 PRENATAL AND NEWBORN TESTING
    8.5 PREIMPLANTATION TESTING
    8.6 DIAGNOSTIC TESTING
    8.7 PHARMACOGENOMIC TESTING
    8.8 NUTRIGENOMIC TESTING
    8.9 FORENSIC TESTING
    8.10 COVID-19 IMPACT ANALYSIS

9 GENETIC TESTING MARKET, BY METHODS 
    9.1 INTRODUCTION
    9.2 MOLECULAR GENETIC TESTING
    9.3 CHROMOSOMAL GENETIC TESTING
    9.4 BIOCHEMICAL GENETIC TESTING
    9.5 OTHERS (IF ANY)
    9.6 COVID-19 IMPACT ANALYSIS

10 GENETIC TESTING MARKET, BY END USERS 
     10.1 INTRODUCTION
     10.2 HOSPITALS
     10.3 CLINICAL LABORATORIES
     10.4 OTHERS (IF ANY)
     10.5 COVID-19 IMPACT ANALYSIS

11 GENETIC TESTING MARKET, BY REGION 
     11.1 INTRODUCTION
     11.2 EUROPE
             11.2.1 ITALY
             11.2.2 GERMANY
             11.2.3 FRANCE
             11.2.4 UK
             11.2.5 SPAIN
             11.2.6 REST OF EUROPE
     11.3 NORTH AMERICA
             11.3.1 US
             11.3.2 CANADA
     11.4 ASIA PACIFIC
             11.4.1 JAPAN
             11.4.2 CHINA
             11.4.3 INDIA
             11.4.4 REST OF ASIA PACIFIC
     11.5 LATIN AMERICA
     11.6 MIDDLE EAST AND AFRICA

12 COMPANY EVALUATION MATRIX AND COMPANY PROFILES
     12.1 COMPANY EVALUATION MATRIX DEFINITION & METHODOLOGY
     12.2 MARKET SHARE ANALYSIS (2021, % OF USD MILLION)
     12.3 COMPETITIVE SCENARIO
             12.3.1 PRODUCT LAUNCHES AND APPROVALS
             12.3.2 COLLABORATIONS
             12.3.3 EXPANSIONS
             12.3.4 ACQUISITIONS
             12.3.5 OTHER DEVELOPMENTS
     12.4 COMPETITIVE LEADERSHIP MAPPING
             12.4.1 VENDOR INCLUSION CRITERIA
             12.4.2 STARS
             12.4.3 EMERGING LEADERS
             12.4.4 PERVASIVE
             12.4.5 EMERGING COMPANIES

13 COMPANY PROFILES
(Business overview, Products offered, Recent developments)*
     13.1 F. HOFFMANN-LA ROCHE LTD.
     13.2 ABBOTT LABORATORIES
     13.3 THERMO FISHER SCIENTIFIC, INC.
     13.4 AGILENT TECHNOLOGIES, INC.
     13.5 BIO-RAD LABORATORIES, INC.
     13.6 ILLUMINA, INC.
     13.7 QIAGEN
     13.8 SIEMENS HEALTHINIER
     13.9 DANAHER CORPORATION
     13.10 HOLOGIC, INC.
     13.11 PERKINELMER INC.
     13.12 MYRIAD GENETICS INC.

14 APPENDIX
     14.1 DISCUSSION GUIDE
     14.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
     14.3 AVAILABLE CUSTOMIZATIONS
     14.4 RELATED REPORTS
     14.5 AUTHOR DETAILS


Request for detailed methodology, assumptions & how numbers were triangulated.

Please share your problem/objectives in greater details so that our analyst can verify if they can solve your problem(s).
4 7 5 5 0  
  • Select all
  • News-Letters with latest Market insights
  • Information & discussion on the relevant new products and services
  • Information & discussion on Market insights and Market information
  • Information & discussion on our events and conferences
    • Select all
    • Email Phone Professional and social network (Linkedin, etc)
Report Code
UC 1129
Published ON
Dec, 2022
Choose License Type
Prebook Now
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Genetic Testing Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
CUSTOMIZED WORKSHOP REQUEST
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
©2023 MarketsandMarkets Research Private Ltd. All rights reserved
DMCA.com Protection Status Website Feedback